Medication info
Diamet Tablets (Metformin Hydrochloride)

Diamet Tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
(Kyungdong Pharmaceutical Co., Ltd.)
Appearance
White, round, film-coated tablet
Packaging
500 tablets/bottle
Approval status
Active

MFDS item code 199302107 · Notified 1993.02.23 · Insurance code 648100330

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dosage should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this medicine must be initiated at a low dose. Take 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses daily and take with meals; a maximum of 2550mg daily may be administered. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the response to treatment with this medicine and identify the minimum effective dose. Measure the blood glycated hemoglobin concentration at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and the blood glycated hemoglobin concentration to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡), who do not have other conditions that may increase the risk of lactic acidosis, with the following dosage adjustment. The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Ingredients

Manufacturer
(Kyungdong Pharmaceutical Co., Ltd.)

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medicine is used for the treatment of type 2 diabetes patients for whom blood sugar control is difficult with diet and exercise alone. It is particularly effective for overweight adult patients and can be used alone or in combination with other oral hypoglycemic agents or insulin. Additionally, it can be used in children over 10 years of age and adolescents during growth, either as monotherapy or in combination with insulin, to aid in blood sugar control. This drug is applicable for patients of various ages who need blood sugar management. It helps safely control blood sugar and assists in diabetes treatment.

How to take

Adult dose

The dosage should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this medicine must be initiated at a low dose. Take 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 doses daily and take with meals; a maximum of 2550mg daily may be administered. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess the response to treatment with this medicine and identify the minimum effective dose. Measure the blood glycated hemoglobin concentration at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and the blood glycated hemoglobin concentration to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡), who do not have other conditions that may increase the risk of lactic acidosis, with the following dosage adjustment. The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Precautions

This drug may cause severe lactic acidosis or hypoglycemia, so it should not be used in patients with severely impaired heart or kidney function, acute infections, or dehydration. It should also not be administered to patients with acute heart failure, acute myocardial infarction, those undergoing radiographic iodine contrast examinations, or those allergic to this drug or biguanide medications. The use of this drug should be avoided in cases of placental insufficiency or risk of preeclampsia during pregnancy, and patients scheduled for surgery should discontinue this medication 48 hours prior to the procedure. This drug may accumulate depending on kidney function, increasing the risk of lactic acidosis, thus regular monitoring of kidney function should be conducted before and during treatment. Careful use is required when dietary intake is irregular or insufficient, when engaging in intense exercise, or when other medications are taken. While taking this medication, gastrointestinal disturbances, metallic taste, rash, anemia, liver function abnormalities, and hypoglycemia may occur, so consultation with a healthcare provider is advised if symptoms arise. Alcohol consumption may increase the risk of lactic acidosis as a side effect of this drug, so it is important to avoid excessive drinking during treatment. Particularly in elderly patients or those with reduced kidney function, adjustments to the dosage and regular monitoring of kidney function are necessary. This medication crosses the placenta during pregnancy; hence it should be used cautiously based on a physician's judgment during preconception, pregnancy, and after delivery. For breastfeeding individuals, consideration should be given to stopping either breastfeeding or the treatment. When used in conjunction with other drugs that may enhance or decrease blood sugar-lowering effects, blood sugar status should be closely monitored, and in acute crises, treatment should be discontinued, and appropriate care should be sought. Finally, it is crucial to regularly monitor blood sugar and blood tests and kidney function to closely observe the treatment effects and any side effects during the use of this drug.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly closed container. It is also recommended to store it at room temperature between 1 and 30 degrees Celsius. Doing so will help maintain the medication's effectiveness for a longer duration.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.